Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-2336
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients With Metastatic Castration-Resistant Prostate Cancer

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
2018English

A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Pd14-11 Health-Related Quality of Life (Hrql) in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Treated With Cabazitaxel (Cbz) in a Prospective Observational Study (Capristana)

Journal of Urology
Urology
2018English

Clinical Concepts for Cabazitaxel in the Management of Metastatic Castration‐resistant Prostate Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie
Oncology
2016English

A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2016English

Cabazitaxel in the Management of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel-Based Chemotherapy

European Oncology and Haematology
OncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy